Category: Cannabis
-
Harborside (HBOR.C) – a U.S.-based cash-generating community-minded cannabis business
Last quarter’s gross revenue was 73% of the company’s current market cap.
-
Heritage Cannabis (CANN.C) rides a sweet October open to a near double, and continues to expand
A widening distribution net with award winning products and it shouldn’t come as much of a surprise that Heritage Cannabis (CANN.C) has had an excellent October so far and shows no signs of slowing down. They’ve widened their distribution and availability chain a little more in the past week, adding their wares with Patient Choice,…
-
Watch me: I can sell you on CLS Holdings (CLSH.C), with its one dispensary, being a better buy than Trulieve (TRUL.C), with 52
Let’s take a step back. Take a breath. Maybe meditate or toss back a tequila shot. Okay, we good for a chat? It’s been a rough few years for the cannabis crowd, and a rough last year for everyone else. With Aurora Cannabis (ACB.T) losing the gross national product of Panama, Chuck Rifici bailing from…
-
Heritage Cannabis (CANN.C) is so close profitability, it’s breaking social distancing rules
Sharples believes that Purefarma, Pura Vida, new contract manufacturing agreements, expansion of Canadian territories, the edibles product launch and the acquisition of Opticann expanding CANN’s U.S. presence will accelerate revenue going forward.
-
Xphyto (XPHY.C) advances its Oral Dissolvable Film (ODF) technology for CBD and THC medical markets
Increased product efficacy and patient convenience is anticipated through faster onset of drug action, more predictable therapeutic activity and ease of use.
-
Isracann (IPOT.C) and Tinley (TNY.C) update shareholders on production profile
Isracann and Tinley update shareholders
-
Heritage Cannabis (CANN.C) to develop vape oil with Sugarbud’s biomass
Heritage is positioning itself to radically expand its sales territory.
-
Plus Products (PLUS.C) 71% costs turnaround shows legitimacy in management, anchors growth
Esteemed California cannabis gummies maker Plus Products (PLUS.C) issued quarterly financials Thursday showing a substantial turnaround as their Nevada and national CBD growth plans take hold. After a 10c per share loss in Q1, the company presented a mere 1c per share loss in Q2, with $4.3 million in revenue, despite COVID-driven slowdowns in Nevada.…
-
Willow Biosciences (WLLW.T) takes the romance (and risk) out of cannabinoid production
Willow Biosciences (WLLW.T) is a Canadian biotech company based in Vancouver, BC, that is using “a proprietary yeast strain laboratory process” to produce commercial quantities of CBD and CBG”.
-
Isracann (IPOT.C) in cat seat as Israeli politicos write new cannabis laws
The beginning of recreational weed in Israel is likely to boost IPOT’s bottom line.